Bromophenol Blue

CAS No. 115-39-9

Bromophenol Blue( —— )

Catalog No. M23332 CAS No. 115-39-9

Bromophenol blue is an acid phthalein dye. Bromophenol blue is used as a tracking dye for electrophoresis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
5MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bromophenol Blue
  • Note
    Research use only, not for human use.
  • Brief Description
    Bromophenol blue is an acid phthalein dye. Bromophenol blue is used as a tracking dye for electrophoresis.
  • Description
    Bromophenol blue is an acid phthalein dye. Bromophenol blue is used as a tracking dye for electrophoresis. Bromophenol blue is also used as a pH indicator with a transition range of pH 3 to 4.6.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    115-39-9
  • Formula Weight
    669.96
  • Molecular Formula
    C19H10Br4O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:50 mg/mL (74.63 mM; Need ultrasonic); H2O:11mg/ml(16.42mM; need ultrasonic)
  • SMILES
    Oc(c(Br)cc(C(c1c2cccc1)(c(cc1Br)cc(Br)c1O)OS2(=O)=O)c1)c1Br
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mendoza L , Gunawardhana T , Batchelor W , et al. Nanocellulose for Gel Electrophoresis[J]. Journal of Colloid and Interface Science, 2019, 540:148-154.
molnova catalog
related products
  • Wnt agonist 1

    Wnt agonist 1 (BML-284) is a potent, selective and , cell-permeable Wnt signaling activator.

  • 3,8'-Biapigenin

    3, 8''-Biapigenin can modulate intracellular ROS production.

  • Milenperone

    Milenperone (R 34009) is a novel anti-invasive compound designed to control behavioral disorders in patients with epilepsy and alcoholism.